Shares of Rosetta Genomics Ltd. (NASDAQ:ROSG) saw unusually-high trading volume on Thursday . Approximately 1,981,821 shares changed hands during mid-day trading, an increase of 1,060% from the previous session’s volume of 170,837 shares.The stock last traded at $1.15 and had previously closed at $1.05.
The company has a 50-day moving average of $1.37 and a 200 day moving average of $1.98. The stock’s market cap is $2.14 million.
About Rosetta Genomics
Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next Generation Sequencing (NGS) and Fluorescence In Situ Hybridization (FISH).
Receive News & Ratings for Rosetta Genomics Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rosetta Genomics Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.